Conversion of Nightingale Health Plc’s EMP shares to Series B shares
Company release, 6 July 2023 at 4:00 p.m. (EEST)
The Board of Directors of Nightingale Health Plc (“Nightingale Health”) has in its meeting on 16 June 2023, approved request of shareholders to convert 60,200 EMP shares to Series B shares in accordance with Article 5 in the Articles of Association.
As a result of conversion of shares, the number of Nightingale Health’s Series A shares is 20,585,924, Series B shares is 39,153,970 and EMP shares is 1,178,565. The conversion does not affect the total amount of shares which is 60,918,459. The number of votes of Nightingale Health’s shares